Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-03-07 @ 7:05 PM
Study NCT ID:
NCT02874651
Status:
TERMINATED
Last Update Posted:
2022-01-11
First Post:
2016-08-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10
Start Date Type:
None
Primary Completion Date:
2018-11-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-01
First Submit QC Date:
None
Study First Post Date:
2016-08-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-25
Last Update Post Date:
2022-01-11
Last Update Post Date Type:
ACTUAL